Atossa Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 Apr 24 | Buy€41,179 | Jonathan Finn | Individual | 25,000 | €1.65 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 22,254 | 0.0177% |
Individual Insiders | 51,158 | 0.0407% |
VC/PE Firms | 7,762,500 | 6.17% |
Institutions | 27,653,804 | 22% |
General Public | 90,311,538 | 71.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,667,615 | €11.7m | 5.12% | no data | |||
7,762,500 | €9.4m | 0% | 3.98% | |||
6,598,296 | €8.0m | 1.73% | no data | |||
2,814,446 | €3.4m | 1.62% | no data | |||
1,732,221 | €2.1m | 4.16% | no data | |||
1,310,070 | €1.6m | -15.5% | no data | |||
954,199 | €1.2m | 257% | no data | |||
446,772 | €541.8k | 3.45% | no data | |||
347,610 | €421.6k | -6.05% | no data | |||
303,649 | €368.3k | -26.2% | no data | |||
250,398 | €303.7k | 0% | 0.03% | |||
249,128 | €302.1k | 143% | no data | |||
199,754 | €242.3k | -4.53% | no data | |||
195,589 | €237.2k | 24.2% | no data | |||
170,733 | €207.1k | 0% | no data | |||
167,718 | €203.4k | 281% | no data | |||
161,899 | €196.3k | -19.6% | no data | |||
136,935 | €166.1k | -47.4% | no data | |||
123,039 | €149.2k | -8.94% | no data | |||
96,223 | €116.7k | -47.4% | no data | |||
94,721 | €114.9k | 101,000% | no data | |||
91,977 | €111.5k | 73% | no data | |||
71,866 | €87.2k | -30.8% | no data | |||
71,772 | €87.0k | 0% | no data | |||
70,793 | €85.9k | 70.8% | no data |